A clinical trial to evaluate the efficacy and safety of PLACENTEX ¿ administered intra-muscular in patients with cutaneous lesions in scleroderma diseases. A clinical trial to evaluate the efficacy and safety of PLACENTEX ¿ administered intra-muscular in p ...
A phase IV, single-arm, open-label clinical trial to evaluate the efficacy and safety of PLACENTEX ¿ Polydeoxyribonucleotide i.m. in patients with fibrotic and atrophic cutaneous lesions in scleroderma diseases. - A clinical trial to evaluate the efficacy and safety of PLACENTEX ¿ administered intra-muscular in p A phase IV, single-arm, open-label clinical trial to evaluate the efficacy and safety of PLACENTEX ¿ ...
Fibrotic and atrophic cutaneous lesions in localized scleroderma diseases. MedDRA version: 20.0;Level: HLT;Classification code 10039711;Term: Scleroderma and associated disorders;System Organ Class: 100000004870;Therapeutic area: Diseases [C] - Skin and Connective Tissue Diseases [C17] Fibrotic and atrophic cutaneous lesions in localized scleroderma diseases. MedDRA version: 20.0;Leve ...